Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov
CERTs banner

Journal Articles


One way of disseminating information learned from projects of the Centers for Education & Research on Therapeutics (CERTs) is through publication in peer-reviewed medical journals. This section shows CERTs journal articles published from 2000 through 2013.

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 

2003

A-E

  • Al-Khatib SA, Allen LaPointe NM, Kramer JM, et al. What clinicians should know about the QT interval. JAMA 2003 Apr 23-30;289(16):2120-2127. Select to access the abstract.
  • Al-Khatib SM, Allen LaPointe NM, Curtis LH, et al. Outpatient prescribing of antiarrhythmic drugs from 1995 through 2000. Am J Cardiol 2003 Jan 1;91(1):91-94. Select to access the abstract.
  • Allen LaPointe NM, Chen A, Hammill B, et al. Evaluation of the dofetilide risk-management program. Am Heart J 2003 Nov;146(5):894-901. Select to access the abstract.
  • Allen LaPointe NM, Pamer CA, Kramer JM. New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance. Pharmacotherapy 2003 Oct;23(10):1316-1321. Select to access the abstract.
  • Allen LaPointe NM, Al-Khatib SM, Kramer JM, et al. Knowledge deficits related to the QT interval could affect patient safety. Ann Noninvasive Electrocardiol 2003 Apr;8(2):157-160. Select to access the abstract.
  • Andrade SE, Majumdar SR, Chan KA, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003 Sep 22;163(17):2052-2057. Select to access the abstract.
  • Brown SA, Ontjes DA, Lester GE, et al. Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis. Osteoporos Int 2003 Jun;14(5):442-449. Select to access the abstract.
  • Bijlsma JW, Boers M, Saag KG, et al. Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis 2003 Nov;62(11):1033-1037. Select to access the abstract.
  • Campbell WH, Califf RM. Improving communication of drug risks to prevent patient injury: proceedings of a workshop. Pharmacoepidemiol Drug Saf 2003 Apr-Mar;12(3):183-194. Select to access the abstract.
  • Chan Ka, Truman A, Gurwitz J, et al. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med 2003 Mar 24;163(6):728-734. Select to access the abstract.
  • Curtis LH, Ostbye T, Sendersky V, et al. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med 2003 Feb 1;114(2):135-141. Select to access the abstract.
  • Everett WW, Coffin SE, Zaoutis T, et al. Smallpox vaccination: a national survey of emergency health care providers. Acad Emerg Med 2003 Jun;10(6):606-611. Select to access the abstract.

F-I

  • Finkelstein JA, Stille C, Nordin J, et al. Reduction in antibiotic use among US children, 1996-2000. Pediatrics 2003 Sep;112(3 Pt 1):620-627. Select to access the abstract.
  • Finkelstein JA, Huang SS, Daniel J, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics 2003 Oct;112(4):862-869. Select to access the abstract.
  • Hagen EA, Lautenbach E, Olthoff K, et al. Low prevalence of colonization with vancomycin-resistant enterococcus in patients awaiting liver transplantation. Am J Transplant 2003 Jul;3(7):902-905. Select to access the abstract.
  • Hennessy S, Bilker WB, Zhou L, et al. Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA 2003 Sep;290(11):1494-1499. Select to access the abstract.
  • Hennessy S, Bilker WB, Weber A, et al. Descriptive analyses of the integrity of a US Medicaid claims database. Pharmacoepidemiol Drug Saf 2003 Mar;12(2):103-111. Select to access the abstract.

J-N

  • Kornick CA, Kilborn MJ, Santiago-Palma J, et al. QTc interval prolongation associated with intravenous methadone. Pain 2003 Oct;105(3):499-506. Select to access the abstract.
  • Lautenbach E, Larosa LA, Kasbekar N, et al. Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use. Arch Intern Med 2003 Mar;163(5):601-605. Select to access the abstract.
  • Lautenbach E, LaRosa LA, Marr AM, et al. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003 Feb;36(4):440-446. Select to access the abstract.
  • Levy RM, Huang EY, Roling D, et al. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol 2003 Apr;139(4):467-471. Select to access the abstract.
  • Liu X, Katchman A, Whitfield BH, et al. In vivo androgen treatment shortens the QT interval and increases the destinies of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res 2003 Jan;57(1):28-36. Select to access the abstract.
  • Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med 2003 Jan 21;138(2):109-118. Select to access the abstract.
  • Metlay JP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicrob Chemother 2003 Apr;51(4):963-970. Select to access the abstract.
  • Metlay JP, Hardy C, Strom BL. Agreement between patient self-report and a Veterans Affairs national pharmacy database for identifying recent exposures to antibiotics. Pharmacoepidemiol Drug Saf 2003 Jan-Feb;12(1):9-15. Select to access the abstract.
  • M'ikanatha NM, Southwell B, Lautenbach E. Automated laboratory reporting of infectious diseases in a climate of bioterrorism. Emerg Infect Dis 2003 Sep;9(9):1053-1057. Select to access the abstract.
  • M'ikanatha NM, Lautenbach E, Kunselman AR, et al. Sources of bioterrorism information among emergency physicians during the 2001 anthrax outbreak. Biosecur Bioterror 2003;1:259-265. Select to access the abstract.
  • Mikuls TR, Mudano AS, Pulley L, et al. Association of race/ethnicity with the receipt of traditional and alternative arthritis-specific health care. Med Care 2003 Nov;41(11):1233-1239. Select to access the abstract.
  • Mudano AS, Casebeer L, Patino F, et al. Racial disparities in osteoporosis prevention in a managed care population. South Med J 2003 May;96(5):445-451. Select to access the abstract.

O-Z

  • Patino FG, Olivieri J, Allison JJ, et al. Nonsterioidal antiinflammatory drug toxicity monitoring and safety practices. J Rheumatol 2003 Dec;30(12):2680-2688. Select to access the abstract.
  • Patino FG, Allison J, Olivieri J, Mudano A, Juarez L, Person S, Mikuls TR, Moreland L, Kovac SH, Saag KG. The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs. Arthritis Rheum 2003 Jun 15;49(3):293-299. Select to access the abstract.
  • Pearson S-A, Ross-Degnan D, Payson A, et al. Changing medication use in managed care: a critical review of the available evidence. Am J Manag Care 2003 Nov;9(11):715-731. Select to access the abstract.
  • Peterson ED, Kaul P, Kaczmarek RG, et al. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol 2003 Nov;42(9):1611-1616. Select to access the abstract.
  • Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003 Nov 1;158(9):915-920. Select to access the abstract.
  • Ray WA, Daugherty JR, Meador KG. Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy. N Engl J Med 2003 May 8;348(19):1885-1894. Select to access the abstract.
  • Saag KG. Glucocorticoid-induced osteoporosis. Endocrinol Metab Clin North Am 2003 Mar;32(1):135-157. Select to access the abstract.
  • Stiles RA, So SA. Impact of transaction costs on healthcare outcomes. Expert Rev Pharmacoecon Outcomes Res 2003 Jun;3(3):283-291. Select to access the abstract.
  • Strom BL. Risk assessment of drugs, biologics and therapeutic devices: present and future issues. Pharmacoepidemiol Drug Saf 2003 Dec;12(8):653-662. Select to access the abstract.
  • Walson PD, Cox S, Utkin I, et al. Clinical use of a simultaneous HPLC assay for indinavir, saquinavir, ritonavir, and nelfinavir in children and adults. Ther Drug Monit 2003 Oct;25(5):588-592. Select to access the abstract.

 

AHRQAdvancing Excellence in Health Care